Wang L, Zhao X, Du J, Liu M, Feng J, Hu K
alcohol free
7.1.1.1 Monoclonal antibodies Antibodies targeting specific cytokines, such as TNF- inhibitors (e.g., infliximab and adalimumab), have been shown to decrease the levels of systemic inflammation and reduce BBB dysfunction (Esposito and Cuzzocrea, 2009)
Long-term systemic treatment with PregS rescues impaired episodic memory and poor discriminative abilities in the DAT KO mice without adverse effects
Treatment of rats with colitis using sulforaphane reduces NO and MDA levels, accompanied by increased GPx and reduced glutathione levels, demonstrating its therapeutic antioxidant properties ( Supplementary Table 1 )
Product Highlights & Quick Facts Product Type: Blended Research Peptide (GHRH + GHRP) Total Content: 10mg per vial (typically blended in a 1:1 or specific ratio [verify with brand/source]) Format: Lyophilized (freeze-dried) white powder Purity Standard: $\ge$ 98% (verified via HPLC and Mass Spectrometry) Intended Use: In vitro and in vivo laboratory research purposes only Storage Requirements: Store at -20C for long-term stability
